Displaying 301 - 310 of 632
Remembering Michael Cobden
Updated:
Throughout his life, Michael Cobden was a healthy, active person. As a child he played many sports including rugby, soccer, track and field, tennis and golf, and even into his early 70s he could often be found with his wife Jane on long, brisk walks through Point Pleasant Park…
“I'm still here": Living with multiple myeloma for 12 years
Updated:
David Johnson, of BC, first diagnosed with the disease in 2012 in his early 50s, has experienced 2 relapses, 2 stem cell transplants, and participated in a clinical trial for CAR T-cell therapy. Dr. Anthony Reiman, medical oncologist in NB, talks about advances in MM treatment.
Myeloma
Myelodysplastic Syndromes (MDS): A Conversation with Dr. Rena Buckstein
Updated:
Dr. Rena Buckstein from Odette Cancer Centre in Toronto shares the basics of myelodysplastic syndromes (MDS) diagnosis, treatment, and side effects.
Myelodysplastic syndromes
Graft vs Host Disease (GvHD)
Updated:
Graft vs Host Disease, known as GvHD, is a side effect of a life saving procedure. People who undergo an allogeneic stem cell transplant - when a donor's stem cells are transplanted into the recipient - can experience either acute or chronic GvHD. In this podcast, listen to…
Treatment and side effects
Causes of blood cancer - What we know - Innovation and Research Webcast Series 2023
Updated:
In this presentation, Dr. John Dick, one of Canada’s pioneering scientists in the field of “cancer stem cells”, will explain how his research into the causes of blood cancers holds the promise for improved treatments and quality of life for Canadians affected by blood cancers.
Diagnosis and tests, Leukemia, Research
Artificial Intelligence and the Future of Blood Cancers webcast
Updated:
In this 2025 webcast, four scientists funded by the LLSC's AI Catalyst Grant talk about their work investigating how AI / machine learning can speed up discovery and detection of blood cancers in their research work. Moderated by Dr. Paul O'Connell, LLSC Research…
Research
Research Champions
Updated:
Research Champions are individuals who made an exceptional contribution to the blood cancer community.
They are people who want to see cures for blood cancers in our lifetime and will stop at nothing to make it happen.
They are people who want to see cures for blood cancers in our lifetime and will stop at nothing to make it happen.
Blood Cancer Day 2025 at University of Toronto's Faculty of Pharmacy
Updated:
The LLSC was invited to present at Blood Cancer Day on Saturday, May 3, 2025 at the University of Toronto Leslie Dan Faculty of Pharmacy.
CLL Live 2025: All things chronic lymphocytic leukemia
Updated:
CLL is one of the most common types of leukemia in adults; CLL Canada holds it free annual conference for patients by patients.
Understanding multiple myeloma
Updated:
Multiple myeloma, or MM, is a type of blood cancer that starts in the bone marrow. Multiple myeloma affects plasma cells, a type of white blood cell that normally fights infection, turning healthy cells into cancer cells that can damage blood, bones and kidneys.
Myeloma